Interrelationships of Hyperinsulinism and Hypertriglyceridemia in Young Patients with Coronary Heart Disease
|
|
- Jason Barton
- 5 years ago
- Views:
Transcription
1 Interrelationships of Hyperinsulinism and Hypertriglyceridemia in Young Patients with Coronary Heart Disease By MANUEL TZAGOURNIS, M.D., Ross CHILES, M.D., JOSEPH M. RYAN, M.D., AND THOMAS G. SKILLMAN, M.D. SUMMARY Fasting serum lipid levels, glucose tolerance, and immunoreactive insulin concentrations of 50 young patients with coronary heart disease (CHD) and 30 control subjects were evaluated to study the interrelationships of these metabolic factors. Abnormalities in one or more of these factors could be shown in 90% of the patients and 20% of the control subjects. Thirty-four of the 50 patients had elevated cholesterol or triglyceride levels, or both, 30 had abnormally elevated or delayed insulin responses after glucose, and 17 had abnormal glucose tolerance. A significant correlation existed between serum triglyceride and insulin concentrations. When insulin levels were reduced by phenformin, triglyceride concentrations fell toward normal. These findings indicate that carbohydrate, insulin, and lipid abnormalities are rather prevalent in patients with CHD. Excessive insulin secretion secondary to mild glucose intolerance probably induces hepatic synthesis of triglycerides and hypertriglyceridemia. Dietary alterations or pharmacological agents may help to control some of the metabolic abnormalities associated with premature CHD. Additional Indexing Words: Atherosclerosis Diabetes Hyperglycemia Hyperlipidemia RECENT STUDIES suggest that atherosclerosis may involve a continuum in which hyperlipidemia and carbohydrate intolerance exercise pathophysiological significance. Patients with coronary heart disease (CHD) are commonly found to have elevated serum cholesterol and triglyceride concentrations.' 2 Many subjects with CHD also have abnormal glucose tolerance and immunoreactive insulin responses after carbohydrate loading.3 4 Although subjects with clinical diabetes mellitus as a group develop premature anti From the Divisions of Endocrinology and Metabolism, and Cardiology, Department of Medicine, The Ohio State University College of Medicine, Columbus, Ohio. Supported in part by U. S. Public Health Service Training Grant T01-AM05118 and U. S. Public Health Service General Research Grant 5-S01-FR , and the U. S. Vitamin and Pharmaceutical Corp extensive atherosclerosis, hyperglycemia, the traditional identifying metabolic marker for the diabetic state, does not seem to be directly related to the pathogenesis of atherosclerosis. Hyperlipidemia, on the other hand, may well play an important role in the genesis of the atherosclerotic lesion. The hormone insulin is fundamental to the attainment of both glucose and lipid homeostasis. The serum immunoreactive insulin response to orally administered glucose in maturity-onset diabetes is characterized by a delayed secretion, and the serum insulin levels are often elevated. Patients with hypertriglyceridemia also have been reported to have impaired glucose tolerance and elevated plasma insulin responses.5, 6 Farquhar and associates7 have reported that elevations of plasma glucose and insulin concentrations correlate well with the magnitude of the plasma triglyceride increase after
2 HYPERINSULINISM AND HYPERTRIGLYCERIDEMIA 1157 Table 1 Characteristics and Laboratory Data of CHD and Control Patients Age Patients (yr) Sex TG* Cholf IA* Coronary heart disease patients 30 M M M M M F M M M M M M M M M M M M M M M M M M M M M M M M M M M M M F M M M M M M M F M M M M F M Circulation, Volume XXXVIII. December 1968 Table 1 (continued) Age Patients (yr) Sex TG* Cholt Control patients 1 30 M M M M M F M M M M M M F M F M M M M M F M M M M M M M M m *Triglyceride level in mg%. IA* tcholesterol level in mg%. *Area under 3-hour insulin curve in milli-unit minutes. carbohydrate feeding. They suggested that elevated insulin levels in the presence of normal or high glucose levels enhance hepatic production of triglycerides. This view is consistent with other clinical studies indicating that the intake of sucrose and other simple carbohydrates, in contrast to complex carbohydrates such as starch, induces a sharp increase in blood glucose, insulin, and triglyceride concentrations.8-10 Eliminating the simple sugars usually brings the serum triglycerides back to normal. In this report various measurements were made to study the interrelationships of carbohydrate, insulin, and lipid metabolism in
3 1158 TZAGOURNIS ET AL. young patients with CHD. As a group, these patients displayed decreased glucose tolerance, abnormal insulin secretion, and elevated serum cholesterol and triglyceride concentrations. In addition, serum insulin levels correlated well with the fasting serum triglyceride concentrations. Methods Fifty patients with coronary heart disease (CHD) between the ages of 26 and 49 years were compared with 30 control subjects (table 1). Young patients were chosen because they might be expected to show certain metabolic abnormalities related to the development of atherosclerosis. The mean age of the group with CHD was 40 years and that of the control group, 36 years. The criteria for the diagnosis of coronary heart disease were: (1) definite myocardial infarction, confirmed by electrocardiographic changes or serum enzyme elevations or both, (36 patients); (2) angina pectoris with angiographic evidence of coronary atherosclerosis (seven patients); and (3) angina pectoris associated with electrocardiographic evidence of coronary insufficiency (seven patients). Known diabetics were excluded from the study. Since obesity is associated with increased serum insulin levels, control subjects as well as patients exceeding 115% of ideal body weight (as indicated in the Metropolitan Life Insurance Company weight tables) were also excluded. The patients with myocardial infarctions were not studied until at least 1 month following recovery from the acute episode. Patients and control subjects were ambulatory at the time of the investigation and were instructed to eat a normal diet with ample carbohydrate for 2 days preceding the testing. Serum cholesterol was determined according to the method of Abell and coworkers'1; serum phospholipids, by the method of Lowry and associates.12 Serum triglycerides were calculated from serum esterified fatty acids by the technique of Stern and Shapiro.'3 A 3-hour glucose tolerance test was performed with sampling at 0,,lk, 1, 2, and 3 hours for both glucose and insulin after 75 g of glucose had been administered. Determinations were made for glucose on whole blood by the Hoffinan method on the autoanalyzer'4 and serum immunoreactive insulin by the technique of Grodsky and Forsham.'5 Table 2 The Various Abnormalities Found in the Tested Subjects To obtain further information concerning lipid and insulin interrelationships, 30 patients were given phenformin, an oral hypoglycemic agent, which has also been shown to reduce serum insulin levels in obese and diabetic patients.16 The dosage ranged from 50 mg to 150 mg per day. After treatment for approximately 2 months, the serum lipids, glucose tolerance, and serum insulin measurements were repeated. Serum lipid determinations were subsequently performed at approximately 3-month intervals for 1 year. Results Frequency of Abnormal Findings in Patients with Coronary Heart Disease and Control Subjects Abnormalities of the serum lipids, serum insulin response, or glucose tolerance were 50 Patients 30 Control Abnormalities* with CHD subjects Insulin, cholesterol, and triglyceride 8 Insulin and cholesterol 5 Insulin only 5 1 Cholesterol only 5 2 Cholesterol and triglyceride 4 Insulin, carbohydrate, and triglyceride 4 1 Insulin, carbohydrate, and cholesterol 3 Insulin and carbohydrate 3 Carbohydrate only 3 Insulin, carbohydrate, cholesterol, and triglyceride 2 Triglyceride only 1 2 Triglyceride and carbohydrate 1 Cholesterol and carbohydrate 1 Total patients with abnormalities 45 (90%) 6 (20%) *Abnormal values were: Cholesterol-serum levels exceeding 290 mg%; triglycerides-serum levels exceeding 170 mg%; insulin-response manifested by elevated levels or by delayed secretion; carbohydrate-abnormal glucose tolerance test.
4 HYPERINSULINISM AND HYPERTRIGLYCERIDEMIA 1159 significantly greater in the patients with CHD than in the control subjects. One or more metabolic abnormalities could be demonstrated in 45 (90%) of the 50 patients and in six (20%) of the 30 control subjects (table 2) Ȧn elevation of the serum lipid levels was found in 34 of the 50 patients. The lipid levels were considered to be elevated if the serum cholesterol was greater than 290 mg% or the serum triglycerides was greater than 170 mg%. Fourteen patients had serum cholesterol concentrations exceeding 290 mg% and normal triglyceride levels. Six patients showed an elevated serum triglyceride value with a normal cholesterol concentration. The remaining 14 patients had an elevation in both serum cholesterol and triglyceride levels. Twentyfour of the 34 patients with elevated serum lipids also had an abnormal serum insulin response or impaired glucose tolerance, or both. The mean cholesterol value of the 50 patients was mg% (one standard deviation) as compared to 222±46 mg% in the control subjects. The mean triglyceride concentration was mg% in the patient group and mg% in the control group (table 3). An abnormal serum insulin response, manifested by elevated levels or delayed peak levels occurring at the 2 or 3-hour interval, was found in 30 of the 50 patients. The serum insulin level was considered to be elevated if it exceeded the mean plus two standard deviations of the control group's value for any given interval during the glucose tolerance test. The mean insulin response of the patients after glucose was higher at each interval than that observed in the control subjects (table 3). The total mean insulin concentration of the 50 patients, expressed as the area encompassed by the 3-hour curve, was mu-min (milli-unit minutes). This was significantly higher than the mu-min found in the 30 control subjects (P <0.05). Although no patient had known diabetes mellitus prior to the studies, 17 of the 50 patients had an abnormal glucose tolerance test according to the criteria of Wilkerson.17 The relative mildness of the abnormal glucose tolerance is reflected by the fact that no fasting blood glucose level exceeded 100 mg%. The mean glucose values at the and 2-hour intervals were, however, higher in the patient group than in the control subjects (table 3). Correlation of Serum Triglyceride Measurements with Other Variables in the Patients with Coronary Heart Disease (Table 4) A correlation between the fasting serum triglyceride concentration was sought with the following: (1) peak insulin level; (2) total insulin area under the 3-hour curve (mu-min); (3) serum cholesterol concentration; (4) 2-hour glucose level and (5) the percentage of ideal body weight. Fasting triglyceride values correlated well with the area under the 3-hour insulin curve (r = 0.34, P < 0.02). Figure demonstrates the tendency for the insulin concentrations to increase as the serum triglyceride levels rose. Correlations of serum triglyceride levels were also good with the peak insulin level (r = 0.28, P < 0.05) and the serum cholesterol Table 3 Comparison of Mean Lipid Glucose and Insulin Concentrations in 50 Patients with Coronary Disease and 30 Control Subjects Choles- Triglycterol eride Glucose (mg%) Insulin (,uu i ml) (mg%) (mg%) F '2 hr 1 hr 2 hr 3 hr F /2 hr 1 hr 2 hr 3 hr Controls Mean SD Coronary patients Mean SD
5 ISTANDARD ERROR TZAGOURNIS ET AL. Meon Voluev of 30 patiels befor* treatment After 2mosthi treatment with pheormls I STANDARD ERROR 20 I- Ci' E 100- w z N 13 N 13 N=12 N=12 First Quartile Second Quartile Third Quartile FourthQuartile (O -100) ( ) ( ) (>235) TRIGLYCERIDES mg.% Figure 1 Mean fasting serum concentrations of triglycerides in each quartile plotted against the mean insulin secretion (mu-min) of 50 patients with coronary heart disease. level (r = 0.31, P <0.05). No significant correlation existed between triglycerides and either the 2-hour glucose concentrations (r= 0.11, P>0.10) or percentage of ideal body weight (r=0.19, P>0.10). The poor relationship between the triglyceride level and body weight may have been due to the exclusion of individuals exceeding 115% of ideal body weight. Effects of Treatment with Phenformin Thirty of the 50 patients, all of whom had one or more abnormalities of their carbohydrate, insulin, or lipid metabolism, agreed to ll. a z HOURS Figure 2 The mean and one standard error of glucose and insulin values in 30 patients with CHD compared to values obtained after phenformin treatment for approximately 2 months. take phenformin and be re-evaluated at regular intervals. After treatment with phenformin, 50 to 150 mg per day for approximately 2 months, the serum insulin levels decreased in 26 of 30 patients. Figure 2 demonstrates that the mean insulin response was lower at each corresponding interval after glucose than that observed in the same Table 4 Summary of the Correlations (r) of Mean Values Among the 50 Patients with CHD Insulin Peak 2-Hour % Ideal Triglyceride area insulin Cholesterol glucose body weight Triglyceride 0.34* 0.28* 0.31* Insulin area 0.34* 0.90* Peak insulin 0.28* 0.90* Cholesterol 0.31* Hour glucose % Ideal body weight *P <0.05.
6 HYPERINSULINISM AND HYPERTRIGLYCERIDEMIA 25 1 E 20- E z 15-0 hi w 10 - z z BEFORE AFTER Phenformin 2 months INSULIN I STANDARD ERROR BEFORE AFTER AFTER Phenformin 2montt year Figure 3 TRI GLYCERI DES X 150 OCa -125 i -100 CD tr -75 *50 t -25 ) Response of insulin secretion (reflected by the area under the 3-hour curve) and fasting serum triglyceride levels to phenformin in 30 patients with coronary heart disease. patients prior to treatment. The mean of the areas under the 3-hour insulin curves decreased significantly from mu-min to mu-min (P < 0.05).. As expected, the levels of the glucose obtained during the tolerance tests decreased after treatment (fig. 2). The decrease in insulin secretion was accompanied by a fall in the level of serum triglycerides (fig. 3). The mean pretreatment serum triglyceride concentration of 191 mg% decreased to 142 mg% after 2 months. Sequential follow-up serum lipid concentrations at 3-month intervals were obtained on 25 of the 30 patients and the mean triglyceride level decreased to 127 mg% after 12 months of treatment (P <0.05). There was no significant change in body weight during the treatment. The mean initial weight of 161 lb decreased to 160 lb after 2 months and to 155 lb after 12 months of treatment. No attempt was made to alter the diet which the patients were taking at the time that they were referred for the study program. Discussion Despite the identification of numerous metabolic abnormalities associated with CHD, it is not clear whether any one factor is directly or independently related to the development of coronary atherosclerosis. For CirVdation, Volume XXXVIII, pecember 1, example, it is not known whether hyperglycemia alone plays a major role in atherogenesis, or whether its presence promotes abnormal lipid metabolism which then is basic to the atherosclerotic process. Therefore, it is useful to study the interrelationships of the metabolic abnormalities found in patients with CHD. This study of 50 patients with premature coronary atherosclerosis disclosed distinct abnormalities of glucose, lipid, and insulin metabolism in 90% of the group. Since the subjects were selected because they had definite CHD, the finding of elevated serum triglyceride and cholesterol concentrations was not surprising." 18 The high prevalence of abnormal glucose tolerance tests was somewhat unexpected because subjects with known clinical diabetes and elevated fasting blood glucose levels were deliberately excluded. This study also disclosed a significant positive correlation between fasting serum triglyceride concentrations and the magnitude of glucose-induced insulin secretion as well as the level of serum cholesterol. The association of hypertriglyceridemia and hypercholesterolemia, commonly found in our patients, is not unusual. Endogenously synthesized triglycerides are transported in the blood chiefly as pre-beta lipoproteins. These lipoproteins also transport cholesterol and, when increased, are associated with relative hypercholesterolemia. Although the association of a constellation of abnormal metabolic characteristics does not necessarily imply a causal relationship between them, there is good evidence to support the concept that insulin hypersecretion may provoke hypertriglyceridemia. When healthy individuals are fed a diet very high in carbohydrate, hypertriglyceridemia can be induced in them.'9 Furthermore, when subjects with elevated triglyceride levels are fed a diet which is poor in simple sugars, their serum lipid concentration almost always falls.8 It has also been shown that healthy persons secrete more insulin in response to feeding of the simple sugars, glucose and sucrose, than to a calorically equal amoiunt
7 1162 of starch.'0 These observations support the hypothesis of Reaven and associates20 which states that increased hepatic synthesis of triglycerides and release may play a causal role in the establishment of hypertriglyceridemia. Insulin plays an important role in the "fed state" in storing calories not only as glycogen, but also as protein and fat. It appears probable that impairment of glucose uptake by muscle and adipose tissue permitted an augmented insulin secretion in the CHD patients. Although the patients with mild glucose intolerance released less insulin for the degree of hyperglycemia present,2' their absolute output of insulin was greater than in the normal subjects. The observed excess of insulin, although insufficient to permit normal glucose uptake by cells, could have been adequate to permit an increase in hepatic triglyceride synthesis with subsequent hypertriglyceridemia. The conversion of glucose to triglycerides by the liver is, of course, not the only source of this lipid in man. Primary fat-induced lipemia, in contrast to "ccarbohydrate-induced" lipemia, has its origin in exogenous or dietary fat. In exogenous hypertriglyceridemia there is an inherited or acquired inability to dispose of chylomicrons, presumably due to a deficiency of the enzyme, lipoprotein lipase.22, 23 Still another source of triglyceride is hepatic conversion of free fatty acids (FFA) liberated by adipose tissue. A variety of stimuli may cause FFA mobilization in excess of the liver's capacity to oxidize them and therefore, facilitate their conversion to triglycerides. This mechanism may be operating in the relatively severe diabetic who has insufficient insulin for inhibition of adipose tissue lipolysis. This defect permits exaggerated FFA mobilization and increased hepatic triglyceride conversion. It seems, then, that insulin plays a major role in regulating normal lipid metabolism and that either abnormally increased or deficient amounts of this hormone can result in hypertriglyceridemia. Patients with CHD have been shown to have normal fasting levels of FFA TZAGOURNIS ET AL. as well as an adequate decline in FFA concentrations after a glucose load.4 It is, therefore, likely that both peripheral lipolysis and lipogenesis are normal in CHD patients, and that the hypertriglyceridemia is related to insulin-dependent, carbohydrate-induced hepatic synthesis. We hypothesized that a reduction of insulin secretion might be attended by an associated reduction in triglycerides. The biguanide, phenformin, has been demonstrated to decrease serum insulin levels in both obese and diabetic subjects.'6 Accordingly this agent was given to 30 of the CHD patients and follow-up studies were instituted. The evidence indicated that phenformin-induced decreases in blood glucose and insulin levels were associated with a fall in serum triglyceride concentrations toward normal. It is noteworthy that the lower levels persisted for a relatively long period with continued treatment. The close interrelationships of carbohydrate, insulin, and lipid metabolism make it difficult to estimate the importance of any single abnormality in the process of atherogenesis. Because atherosclerotic lesions in man contain triglycerides, cholesterol, phospholipids, and other substances such as mucopolysaccharides and fibrous tissue, emphasis has been placed on serum lipids in the pathogenesis of the disease. Certainly, individuals with elevated cholesterol levels without associated carbohydrate, triglyceride, or insulin abnormalities develop premature and extensive CHD. On the other hand, it is important to identify as many biochemical abnormalities as possible in a disease of unknown etiology. It is possible, for example, that exposure of arterial intima to elevated levels of insulin over a prolonged period exerts changes conducive to lipid accumulation by this tissue. Mahler24 has demonstrated that insulin not only stimulates lipid synthesis in arterial tissue by in vitro techniques, but also inhibits lipolytic activity. Both of these actions of insulin would favor lipid accumulation in the intima. Circulation, Volu7ne XXXVIII, December 1968
8 HYPERINSULINISM AND HYPERTRIGLYCERIDEMMIA 1163 An understanding, therefore, of the interrelationships of insulin and triglyceride metabolism with other biochemical changes may be useful in studying the pathogenesis of the disease process as well as in identifying susceptible individuals. This concept is consistent with the hypothesis that dietary alteration, such as decreased simple carbohydrate intake, or pharmacological agents may control some of the metabolic abnormalities associated with atherosclerosis. References 1. KANNEL, W. B., DAWBER, T. R., FRIEDMAN, G. D., GLENNON, W. E., AND MCNAMARA, P. M.: Risk factors in coronary heart disease: Evaluation of several lipids as predictors of coronary heart disease, Framingham study Ann Intern Med 61: 888, OSTRANDER, L. D., NEFF, B. J., BLOCK, W. D., FRANCIS, T., JR., AND EPSTEIN, F. H.: HYperglycemia and hypertriglyceridemia amona persons with coronary heart disease. Ann Intern Med 67: 34, PETERS, N., AND HALES, C. N.: Plasma insulin concentrations after myocardial infarctions. Lancet 1: 1144, TZAGOURNIS, M., SEIDENSTICKER, J. F., AND HAMWI, G. J.: Serum insulin, carbohydrate, and lipid abnormalities in patients with premature coronary heart disease. Ann Intern Med 67: 42, ALBRINK, M. J., AND DAVIDSON, P. C.: Impaired glucose tolerance in patients with hypertriglyceridemia. J Lab Clin Med 67: 573, DAVIDSON, P. C., AND ALBRINK, M. J.: Abnormal plasma insulin response with high plasma triglycerides independent of clinical diabetes or obesity. J Clin Invest 45: 1000, FARQUHAR, J. W., FRANK, A., GRoss, R. C., AND REAVEN, G. M.: Glucose, insulin, and triglyceride responses to high and low carbohydrate diets in man. J Clin Invest 45: 1648, Kuo, P. T.: Hyperglyceridemia in coronary artery disease and its management. JAMA 201: 87, COHEN, A. M., KAUFMANN, N. A., POZNANSKI, R., BLONDHEIM, S. H., AND STEIN, Y.: Effect of starch and sucrose on carbohydrate-induced byperlipemia. Brit Med J 1: 339, SWAN, D. C., DAVmSON, P., AND ALBRINK, M. D.: Effect of simple and complex carbohydrate on plasma nonesterified fatty acids, plasma sugar, and plasma insulin during oral carbohydrate tolerance tests. Lancet 1: 60, ABELL, L. L., LEVY, B. B., BRODIE, B. B., AND KENDALL, F. E.: Simplified method for estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem 195: 357, LOWRY, 0. H., ROBERTS, N. R., LEINER, K. T., Wu, M. L., AND FARR, A. L.: Quantitative histochemistry of brain: Chemical methods. J Biol Chem 207: 1, STERN, I., AND SHAPIRO, B.: Rapid and simple method for determination of esterified fatty acids and for total fatty acids in blood. Brit J Clin Path 6: 158, HOFFMAN, W. S.: Rapid photoelectric method for determination of glucose in blood and urine. J Biol Chem 120: 51, GRODSKY, G. M., AND FORSHAM, P. H.: Immunochemical assay of total extractable insulin in man. J Clin Invest 39: 1070, GRODSKY, G. M., KARAM, J. C., PAVLATOS, F. C., AND FORSHAM, P. H.: Reduction by phenformin of excessive insulin levels after glucose loading in obese and diabetic subjects. Metabolism 12: 278, WILKERSON, H. L. C.: Diagnosis: Oral glucose tolerance tests. In Diabetes Mellitus: Diagnosis and Treatment, edited by T. S. Danowaski. Amer Diabetes Assoc., Inc., N. Y., 1964, pp ALBRINK, M. J., MEIGS, J. W., AND MAN, E. B.: Serum lipids, hypertension, and coronary artery disease. Amer J Med 31: 4, Kuo, P. T.: Dietary sugar in the production of hypertriglyceridemia in patients with hyperlipemia and atherosclerosis. Trans Ass Amer Physicians 78: 97, REAVEN, C. M., LERNER, R. L., STERN, M. P., AND FARQUHAR, J. W.: Role of insulin in endogenous hypertriglyceridemia. J Clin Invest 46: 1756, SELTZER, H. S., ALLEN, E. W., HERRON, A. L., JR., AND BRENNAN, M. T.: Insulin secretion in response to glycemic stimulus: Relation of delayed initial release to carbohydrate intolerance in mild diabetes mellitus. J Clin Invest 46: 323, HAVEL, R. J., AND GORDON, R. S., JR.: Idiopathic hyperlipidemia: metabolic studies in an affected family. J Clin Invest 39: 1777, BAGDADE, J. D., PORTE, D., JR., AND BIERMAN, E. L.: Diabetic lipemia: Form of acquired fat-induced lipemia. New Eng J Med 276: 427, MAHLER, R.: Diabetes and arterial lipids (abst.). Quart J Med 34; 484, 1965.
Pathophysiology of Lipid Disorders
Pathophysiology of Lipid Disorders Henry Ginsberg, M.D. Division of Preventive Medicine and Nutrition CHD in the United States CHD is the single largest killer of men and women 12 million have history
More informationPlasma Triglyceride Concentration and Plasma Free
Journal of Clinical Investigation Vol. 3, No. 1, 196 Plasma Triglyceride Concentration and Plasma Free Fatty Acid Changes in Response to Norepinephrine in Man * (From the University of Melbourne Department
More informationEFFECT OF PREVIOUS STARVATION ON THE RESPONSE OF
EFFECT OF PREVIOUS STARVATION ON THE RESPONSE OF PLASA LIPIDS AND FREE FATTY ACIDS TO A FAT EAL* By ARGARET J. ALBRINK t AND ROBERT S. NEUWIRTH t (From the Department of Internal edicine, Yale University
More information1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones?
1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones? 3How are dietary lipids transported? 4How lipids synthesized in the liver are transported? 5 Lipoprotien
More informationRELATIONSHIP BETWEEN DIETARY CARBOHYDRATES AND FATS IN THEIR INFLUENCE ON SERUM LIPID CONCENTRATIONS
Clinical Science (1972) 43,265-214. RELATIONSHIP BETWEEN DIETARY CARBOHYDRATES AND FATS IN THEIR INFLUENCE ON SERUM LIPID CONCENTRATIONS I. MACDONALD Department of Physiology, Guy s Hospital Medical School,
More information2.5% of all deaths globally each year. 7th leading cause of death by % of people with diabetes live in low and middle income countries
Lipid Disorders in Diabetes (Diabetic Dyslipidemia) Khosrow Adeli PhD, FCACB, DABCC Head and Professor, Clinical Biochemistry, The Hospital for Sick Children, University it of Toronto Diabetes A Global
More informationThe Role of Endogenous Insulin in Different Hyperlipidemie States
Diabetologia 8, 215--220 (1972) 9 by Springer-Verlag 1972 The Role of Endogenous Insulin in Different Hyperlipidemie States M. TZAGOURNIS, R. CHILES, J. HERROLD, and T. SKILLMAN Department of Medicine,
More informationMetabolic Syndrome. DOPE amines COGS 163
Metabolic Syndrome DOPE amines COGS 163 Overview - M etabolic Syndrome - General definition and criteria - Importance of diagnosis - Glucose Homeostasis - Type 2 Diabetes Mellitus - Insulin Resistance
More informationJMSCR Vol 05 Issue 05 Page May 2017
www.jmscr.igmpublication.org Impact Factor 5.84 Index Copernicus Value: 83.27 ISSN (e)-2347-176x ISSN (p) 2455-0450 DOI: https://dx.doi.org/10.18535/jmscr/v5i5.193 Lipid Profile as Early Predictor of Complication
More informationLipid/Lipoprotein Structure and Metabolism (Overview)
Lipid/Lipoprotein Structure and Metabolism (Overview) Philip Barter President, International Atherosclerosis Society Centre for Vascular Research University of New South Wales Sydney, Australia Disclosures
More informationCardiovascular Complications of Diabetes
VBWG Cardiovascular Complications of Diabetes Nicola Abate, M.D., F.N.L.A. Professor and Chief Division of Endocrinology and Metabolism The University of Texas Medical Branch Galveston, Texas Coronary
More informationDiabetes Mellitus in the Pediatric Patient
Diabetes Mellitus in the Pediatric Patient William Bryant, M.D. Chief of Section Pediatric Endocrinology Children s Hospital at Scott & White Texas A&M University Temple, Texas Disclosures None Definitions
More informationDYSLIPIDEMIA PHARMACOLOGY. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D
DYSLIPIDEMIA PHARMACOLOGY University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D 1 LEARNING OBJECTIVES Know normal cholesterol levels Understand what the role
More informationassociated with serious complications, but reduce occurrences with preventive measures
Wk 9. Management of Clients with Diabetes Mellitus 1. Diabetes Mellitus body s inability to metabolize carbohydrates, fats, proteins hyperglycemia associated with serious complications, but reduce occurrences
More informationEffects of Short-term High-carbohydrate Feeding on. Hypercholesterolaemia*
Archives of Disease in Childhood, 1970, 45, 393. Effects of Short-term High-carbohydrate Feeding on Serum Triglyceride of Children with Familial Hypercholesterolaemia* M. M. SEGALL, I. TAMIR, AUDREY S.
More informationWhat systems are involved in homeostatic regulation (give an example)?
1 UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY GLUCOSE HOMEOSTASIS (Diabetes Mellitus Part 1): An Overview
More informationEffect of Cobalt Chloride on Blood Glucose, Plasma Insulin and Lipids in Rabbits.
Effect of Cobalt Chloride on Blood Glucose, Plasma Insulin and Lipids in Rabbits. Masayoshi Ohmichi, Hiroyuki Morita, Yoko Onuma and Shigeo Koike Department of Hygiene, School of Medicine, Showa University,
More informationTHE EFFECT OF VITAMIN-C THERAPY ON HYPERGLYCEMIA, HYPERLIPIDEMIA AND NON HIGH DENSITY LIPOPROTEIN LEVEL IN TYPE 2 DIABETES
Int. J. LifeSc. Bt & Pharm. Res. 2013 Varikasuvu Seshadri Reddy et al., 2013 Review Article ISSN 2250-3137 www.ijlbpr.com Vol. 2, No. 1, January 2013 2013 IJLBPR. All Rights Reserved THE EFFECT OF VITAMIN-C
More informationCoronary artery occlusion and alcohol intake
British Heart journal, 1977, 39, 289-293 Coronary artery occlusion and alcohol intake JOSEPH J. BARBORIAK, ALFRED A. RIMM, ALFRED J. ANDERSON, MARK SCHMIDHOFFER, AND FELIX E. TRISTANI From the Research
More informationMetabolic integration and Regulation
Metabolic integration and Regulation 109700: Graduate Biochemistry Trimester 2/2016 Assistant Prof. Dr. Panida Khunkaewla kpanida@sut.ac.th School of Chemistry Suranaree University of Technology 1 Overview
More informationAcute and Steady-State Insulin Responses
Acute and Steady-State nsulin Responses to Glucose in Nonobese Diabetic Subjects ROGER L. LERNER and DANEL PORTE, JR. From the University of Washington School of Medicine and Veterans Administration Hospital,
More informationAndrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION
2 Hyperlipidemia Andrew Cohen, MD and Neil S. Skolnik, MD CONTENTS INTRODUCTION RISK CATEGORIES AND TARGET LDL-CHOLESTEROL TREATMENT OF LDL-CHOLESTEROL SPECIAL CONSIDERATIONS OLDER AND YOUNGER ADULTS ADDITIONAL
More informationUNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY
1 UNIVERSITY OF PNG SCHOOL OF MEDICINE AND HEALTH SCIENCES DIVISION OF BASIC MEDICAL SCIENCES DISCIPLINE OF BIOCHEMISTRY AND MOLECULAR BIOLOGY GLUCOSE HOMEOSTASIS An Overview WHAT IS HOMEOSTASIS? Homeostasis
More informationSubject Index. postprandial glycemia and suppression in serum 51 recommendations 119, 120 supplementation pros and cons 118, 119
Acarbose, diabetes prevention trials 32, 33, 40 42 Accelerator hypothesis accelerators beta cell autoimmunity 140, 141, 147, 150, 151 insulin resistance 140, 142 144, 150 obesity 145 148 diabetes risk
More informationNormal Fuel Metabolism Five phases of fuel homeostasis have been described A. Phase I is the fed state (0 to 3.9 hours after meal/food consumption),
Normal Fuel Metabolism Five phases of fuel homeostasis have been described A. Phase I is the fed state (0 to 3.9 hours after meal/food consumption), in which blood glucose predominantly originates from
More informationImproving Access to Quality Medical Care Webinar Series
Improving Access to Quality Medical Care Webinar Series Presented by The Arizona Telemedicine Program and the Southwest Telehealth Resource Center 2015 UA Board of Regents Welcome AZ, UT, CO, NM & NV FLEX
More informationHormonal Regulations Of Glucose Metabolism & DM
Hormonal Regulations Of Glucose Metabolism & DM What Hormones Regulate Metabolism? What Hormones Regulate Metabolism? Insulin Glucagon Thyroid hormones Cortisol Epinephrine Most regulation occurs in order
More informationchange of free fatty acids during incubation was
EFFECT OF GLUCOSE AND INSULIN ON THE ESTERIFICATION OF FATTY ACIDS BY ISOLATED ADIPOSE TISSUE* By M. S. RABEN AND C. H. HOLLENBERG t (Fromn the Ziskind Research Laboratories, New Englantd Centter Hospital,
More informationINSULIN RESPONSE IN GLUCOSE-TOLERANCE TESTS
THE AMERICAN JOURNAL OF CLINICAL PATHOLOGY Copyright 1967 by The Williams & Wilkins Co. Vol. 47, No. 0 Printed in U.S.A. INSULIN RESPONSE IN GLUCOSE-TOLERANCE TESTS STANLEY BURROWS, M.D. Department of
More information3/20/2011. Body Mass Index (kg/[m 2 ]) Age at Issue (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Mokdad A.H.
U.S. Adults: 1988 Nineteen states with 10-14% 14% Prevalence of Obesity (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Metabolic John P. Cello, MD Professor of Medicine and Surgery, University of California,
More informationBeneficial effects of a high carbohydrate, high fiber diet on hyperglycemic diabetic me& 2
Beneficial effects of a high carbohydrate, high fiber diet on hyperglycemic diabetic me& 2 Tae G Kiehm, MD, James W Anderson,3 MD, and Kyleen Ward, RD ABSTRACT High carbohydrate diets rich in dietary fiber
More information13/09/2012. Dietary fatty acids. Triglyceride. Phospholipids:
CARDIOVASCULAR DISEASES (CVD) and NUTRITION Major cause of morbidity & mortality in Canada & other developed countries e.g., majority of approved health claims on food labels relate to lowering CVD Relation
More informationAltered concentrations of blood plasma
C O N S E N S U S S T A T E M E N T Detection and Management of Lipid Disorders in Diabetes Altered concentrations of blood plasma lipoproteins are powerful predictors of coronary heart disease (CHD) and
More informationChapter (5) Etiology of Low HDL- Cholesterol
Chapter (5) Etiology of Low HDL- Cholesterol The aim of this chapter is to summarize the different etiological factors mainly the role of life-style and different disease conditions contributing to the
More informationGlossary For TheFatNurse s For All Ages Series Apolipoprotein B (APOB or ApoB) are the primary apolipoproteins of chylomicrons and low-density lipoproteins (LDL - known commonly by the misnomer "bad cholesterol"
More informationThe investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India
eissn: 09748369, www.biolmedonline.com The investigation of serum lipids and prevalence of dyslipidemia in urban adult population of Warangal district, Andhra Pradesh, India M Estari, AS Reddy, T Bikshapathi,
More informationLipoproteins Metabolism Reference: Campbell Biochemistry and Lippincott s Biochemistry
Lipoproteins Metabolism Reference: Campbell Biochemistry and Lippincott s Biochemistry Learning Objectives 1. Define lipoproteins and explain the rationale of their formation in blood. 2. List different
More informationChapter 18. Diet and Health
Chapter 18 Diet and Health Risk Factors and Chronic Diseases Interrelationships among Chronic Diseases Chronic Disease Heart Disease and Stroke Hypertension Cancer Diabetes The Formation of Plaques in
More informationDiet and Its Relation to Coronary Heart Disease and Death in Three Populations
Diet and Its Relation to Coronary Heart Disease and Death in Three Populations TAVIA GORDON, ABRAHAM KAGAN, M.D., MARIO GARCIA-PALMIERI, M.D., WILLIAM B. KANNEL, M.D., WILLIAM J. ZUKEL, M.D., JEANNE TILLOTSON,
More informationWeek 3 The Pancreas: Pancreatic ph buffering:
Week 3 The Pancreas: A gland with both endocrine (secretion of substances into the bloodstream) & exocrine (secretion of substances to the outside of the body or another surface within the body) functions
More informationHyperlipidemia. Prepared by : Muhannad Mohammed Supervisor professor : Dr. Ahmed Yahya Dallalbashi
Hyperlipidemia Prepared by : Muhannad Mohammed Supervisor professor : Dr. Ahmed Yahya Dallalbashi Outline The story of lipids Definition of hyperlipidemia Classification of hyperlipidemia Causes of hyperlipidemia
More informationPart 1 Risk Factors and Atherosclerosis. LO1. Define the Different Forms of CVD
Week 3: Cardiovascular Disease Learning Outcomes: 1. Define the difference forms of CVD 2. Describe the various risk factors of CVD 3. Describe atherosclerosis and its stages 4. Describe the role of oxidation,
More informationLipid and Carbohydrate Studies in Coronary Artery Disease
Lipid and Carbohydrate Studies in Coronary Artery Disease By HERMAN L. FALSETTI, M.D., J. DAVID SCHNATZ, M.D., DAVID G. GREENE, M.D., AND IVAN L. BUNNELL, M.D. SUMMARY Twenty-seven patients with arteriographically
More informationReduction of Serum Cholesterol and Triglyceride Levels by the Combined Administration of Neomycin and Clofibrate
Reduction of Serum Cholesterol and Triglyceride Levels by the Combined Administration of Neomycin and Clofibrate By PAUL SAMUEL, M.D., CHARLES M. HOLTZMAN, M.D., EDWARD MEILMAN, M.D., AND IGNACY SEKOWSKI,
More informationManagement of Post-transplant hyperlipidemia
Management of Post-transplant hyperlipidemia B. Gisella Carranza Leon, MD Assistant Professor of Medicine Lipid Clinic - Vanderbilt Heart and Vascular Institute Division of Diabetes, Endocrinology and
More informationPathogenesis of Diabetes Mellitus
Pathogenesis of Diabetes Mellitus Young-Bum Kim, Ph.D. Associate Professor of Medicine Harvard Medical School Definition of Diabetes Mellitus a group of metabolic diseases characterized by hyperglycemia
More informationDiabetologia 9 by Springer-Verlag 1978
Diabetologia 14, 249-253 (1978) Diabetologia 9 by Springer-Verlag 1978 Hepatic Insulin Responsiveness in Patients with ndogenous Hypertriglyceridaemia R.M. Bernstein, B.M. Davis, J.M. Olefsky, and G.M.
More informationMETABOLISM CATABOLIC Carbohydrates Lipids Proteins
Index: - Overview: Catabolism and Anabolism. Few concepts:, NADPH. - Overview: Metabolism glucose, fatty acids and amino acids. - Table summary: Principal anabolic and catabolic pathways, and their main
More informationComprehensive Treatment for Dyslipidemias. Eric L. Pacini, MD Oregon Cardiology 2012 Cardiovascular Symposium
Comprehensive Treatment for Dyslipidemias Eric L. Pacini, MD Oregon Cardiology 2012 Cardiovascular Symposium Primary Prevention 41 y/o healthy male No Medications Normal BP, Glucose and BMI Social History:
More informationInvestigations on the mechanism of hypercholesterolemia observed in copper deficiency in rats
J. Biosci., Vol. 12, Number 2, June 1987, pp. 137 142. Printed in India. Investigations on the mechanism of hypercholesterolemia observed in copper deficiency in rats P. VALSALA and P. A. KURUP Department
More informationdetermination of Triglyceride in Serum Amal Alamri
determination of Triglyceride in Serum Amal Alamri Triglyceride are fatty acid esters of glycerol,and are the main lipids in the diet. They broken down(by lipase) in the small intestine to a mixture of
More informationSugar-Loaded Beverages and the Impact on Cardiovascular Health. Christina M. Shay, PhD, MA
Sugar-Loaded Beverages and the Impact on Cardiovascular Health Christina M. Shay, PhD, MA 1 Presenter Disclosure Information Christina M. Shay, PhD, MA Sugar-Loaded Beverages and the Impact on Cardiovascular
More informationFY 2011 WISEWOMAN Approved ICD-9 Code List
243 Congenital hypothyroidism 245.0 Thyroiditis; Acute thyroiditis 245.1 Thyroiditis; Subacute thyroiditis 245.2 Thyroiditis; Chronic lymphocytic thyroiditis 245.3 Thyroiditis; Chronic fibrous thyroiditis
More informationGlossary For TheFatNurse s For All Ages Series Adipocytes, also known as lipocytes and fat cells, are the cells that primarily compose adipose tissue, specialized in storing energy as fat. Apolipoprotein
More informationLIPID METABOLISM. Sri Widia A Jusman Department of Biochemistry & Molecular Biology FMUI
LIPID METABOLISM Sri Widia A Jusman Department of Biochemistry & Molecular Biology FMUI Lipid metabolism is concerned mainly with fatty acids cholesterol Source of fatty acids from dietary fat de novo
More informationIschemic Heart Disease
Ischemic Heart Disease Insulin, Carbohydrate, and Lipid Interrelationships By MENARD M. GERTLER, M.D., HILLAR E. LFETMA, M.D., ERICH SALusTE, PH.D., JAMES L. ROSENBERGER, B.A., AND ROBERT G. GUTHRIE, B.S.
More informationDietary therapy for different forms of hyperlipoproteinemia
CHOLESTEROL AND CARDIOVASCULAR DISEASE Dietary therapy for different forms of hyperlipoproteinemia SCOTr M. GRUNDY, M.D., PH.D. ABSTRACT Diet is the first line of therapy for hypercholesterolemia. The
More informationTHE CLINICAL BIOCHEMISTRY OF LIPID DISORDERS
THE CLINICAL BIOCHEMISTRY OF LIPID DISORDERS Hormonal regulation INSULIN lipid synthesis, lipolysis CORTISOL lipolysis GLUCAGON lipolysis GROWTH HORMONE lipolysis CATECHOLAMINES lipolysis LEPTIN catabolism
More informationImpact of Exercise on Patients with Diabetes Mellitus
Impact of Exercise on Patients with Diabetes Mellitus Bret Goodpaster, Ph.D. Exercise Physiologist Assistant Professor of Medicine University of Pittsburgh Division of Endocrinology and Metabolism Learning
More informationUse of Glucagon to Prevent and Treat Fatty Liver in Transition Dairy Cows
Animal Industry Report AS 650 ASL R1903 2004 Use of Glucagon to Prevent and Treat Fatty Liver in Transition Cows Donald C. Beitz Jerry W. Young Arnold R. Hippen Rafael A. Nafikov Recommended Citation Beitz,
More informationDiabetes: Definition Pathophysiology Treatment Goals. By Scott Magee, MD, FACE
Diabetes: Definition Pathophysiology Treatment Goals By Scott Magee, MD, FACE Disclosures No disclosures to report Definition of Diabetes Mellitus Diabetes Mellitus comprises a group of disorders characterized
More informationEFFECT OF NICARDIPINE ON FASTING PLASMA LIPIDS AND APOLIPOPROTEINS IN MALE NEW ZEALAND WHITE RABBITS. Kamsiah Jaarin, Nafeeza MI*
REVIEW ARTICLE Malaysian Journal of Medical Sciences, Vol. 6, No. 2, July 1999 (5-11) EFFECT OF NICARDIPINE ON FASTING PLASMA LIPIDS AND APOLIPOPROTEINS IN MALE NEW ZEALAND WHITE RABBITS Kamsiah Jaarin,
More informationinsulin, lipid and lipoprotein levels in twenty-five patients suffering from peripheral arterial disease. Subjects
Postgraduate Medical Journal (July 1972) 48, 409-413. The effect of fenfluramine on glucose tolerance, insulin, lipid and lipoprotein levels in patients with peripheral arterial disease B. P. BLISS M.S.,
More informationHigh density lipoprotein metabolism
High density lipoprotein metabolism Lipoprotein classes and atherosclerosis Chylomicrons, VLDL, and their catabolic remnants Pro-atherogenic LDL HDL Anti-atherogenic Plasma lipid transport Liver VLDL FC
More informationThe health benefits of shellfish: What should we be promoting? Professor Bruce Griffin Nutrition Division Faculty of Health & Medical Sciences
The health benefits of shellfish: What should we be promoting? Professor Bruce Griffin Nutrition Division Faculty of Health & Medical Sciences What should we be promoting? Define health benefits in terms
More informationIndex. Note: Page numbers of article titles are in boldface type.
Heart Failure Clin 2 (2006) 101 105 Index Note: Page numbers of article titles are in boldface type. A ACE inhibitors, in diabetic hypertension, 30 31 Adipokines, cardiovascular events related to, 6 Advanced
More informationATP III (Adult Treatment Panel III) CLASSIFICATION C IN ADULTS
LABORATORY AND RISK FACTORS OF ATHEROSCLEROSIS S R. Mohammadi Biochemist (Ph.D.) Faculty member of Medical Faculty RISK FACTORS FOR CHD Clinical Risk Factors Laboratory Risk Factors MAJOR CLINICAL RISK
More informationAsubstantial minority of adults and adolescents
THE METABOLIC SYNDROME AS A RISK FACTOR FOR TYPE 2 DIABETES AND CARDIOVASCULAR DISEASE Roger S. Blumenthal, MD* ABSTRACT This paper discusses the prevalence and clinical significance of the metabolic syndrome
More informationTerm-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY
MCC-006 POST GRADUATE DIPLOMA IN CLINICAL CARDIOLOGY (PGDCC) 00269 Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY Time : 2 hours Maximum Marks : 60 Note : There will be multiple
More informationPLASMA LIPOPROTEINS AND LIPIDS DETERMINATION OF PLASMA CHOLESTEROL AND TRIGLICERIDE LEVEL
PLASMA LIPOPROTEINS AND LIPIDS DETERMINATION OF PLASMA CHOLESTEROL AND TRIGLICERIDE LEVEL Lipids are characterized by low polarity and limited solubility in water. Their plasma concentration is about 500-600
More informationLDL cholesterol (p = 0.40). However, higher levels of HDL cholesterol (> or =1.5 mmol/l [60 mg/dl]) were associated with less progression of CAC
Am J Cardiol (2004);94:729-32 Relation of degree of physical activity to coronary artery calcium score in asymptomatic individuals with multiple metabolic risk factors M. Y. Desai, et al. Ciccarone Preventive
More informationRole of apolipoprotein B-containing lipoproteins in the development of atherosclerosis Jan Borén MD, PhD
Role of apolipoprotein B-containing lipoproteins in the development of atherosclerosis Jan Borén MD, PhD Our laboratory focuses on the role of apolipoprotein (apo) B- containing lipoproteins in normal
More informationEstablished Risk Factors for Coronary Heart Disease (CHD)
Getting Patients to Make Small Lifestyle Changes That Result in SIGNIFICANT Improvements in Health - Prevention of Diabetes and Obesity for Better Health Maureen E. Mays, MD, MS, FACC Director ~ Portland
More informationBehind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL
Behind LDL: The Metabolism of ApoB, the Essential Apolipoprotein in LDL and VLDL Sung-Joon Lee, PhD Division of Food Science Institute of Biomedical Science and Safety Korea University Composition of Lipoproteins:
More informationPotentiation of Diabetes By Testosterone in Male Rats
Southern Illinois University Carbondale OpenSIUC Honors Theses University Honors Program 5-1989 Potentiation of Diabetes By Testosterone in Male Rats Anne M. Van Abbema Southern Illinois University Carbondale
More informationWhat is Diabetes Mellitus?
Normal Glucose Metabolism What is Diabetes Mellitus? When the amount of glucose in the blood increases, After a meal, it triggers the release of the hormone insulin from the pancreas. Insulin stimulates
More informationEffect of mixed diet on lipid fractions levels in Coronary Heart diseases in adults of western Maharashtra region of India.
Effect of mixed diet on lipid fractions levels in Coronary Heart diseases in adults of western Maharashtra region of India. nervous system frequency provokes transient cerebral Dr.Javed Bakas Mulla, Dept.
More information1. Which one of the following patients does not need to be screened for hyperlipidemia:
Questions: 1. Which one of the following patients does not need to be screened for hyperlipidemia: a) Diabetes mellitus b) Hypertension c) Family history of premature coronary disease (first degree relatives:
More informationFish Oils and Diabetes
Fish Oils and Diabetes Summaries of the latest research concerning fish oils and diabetes Fish oils benefit women with diabetes BOSTON, MASSACHUSETTS. Several studies have found a clear inverse association
More informationTriglycerides in clinical medicine review1
perspectives in nutrition Triglycerides in clinical medicine A review1 Manuel Tzagournis, M.D.2 ABSTRACT There have been many relevant advances in our knowledge of triglycerides as they apply to clinical
More informationUnit IV Problem 3 Biochemistry: Cholesterol Metabolism and Lipoproteins
Unit IV Problem 3 Biochemistry: Cholesterol Metabolism and Lipoproteins - Cholesterol: It is a sterol which is found in all eukaryotic cells and contains an oxygen (as a hydroxyl group OH) on Carbon number
More informationKey Nutritional Considerations & Lab Markers as Adjuncts in Effective Lipid Management. Carmen Ritz, MS Clinical Physiologist
Key Nutritional Considerations & Lab Markers as Adjuncts in Effective Lipid Management Carmen Ritz, MS Clinical Physiologist The Ideal Biomarker to identify risk for CVD Specific accurately identifies
More informationTHE DIFFERENT EFFECTS OF ORAL SUCROSE AND GLUCOSE ON ALIMENTARY LIPAEMIA
Clinical Science (1971) 41, 123-129. THE DIFFERENT EFFECTS OF ORAL SUCROSE AND GLUCOSE ON ALIMENTARY LIPAEMIA J. I. MANN, A. S. TRUSWELL AND B. L. PIMSTONE Department of Medicine, University of Cape Town,
More informationThe changes of serum BDNF, blood lipid and PCI in the elderly patients with coronary heart disease complicated with diabetes mellitus
184 Journal of Hainan Medical University 2016; 22(16): 184-188 Journal of Hainan Medical University http://www.hnykdxxb.com/ The changes of serum BDNF, blood lipid and PCI in the elderly patients with
More information-21- ANIMAL FAT IN THE DIET. by A. J. Siedlerll
-21- ANIMAL FAT IN THE DIET by A. J. Siedlerll One of the problems confronting the meat industry is the implication that saturated fats in the human diet may cause hardening of the arteries or arteriosclerosis.
More informationChanging Diabetes: The time is now!
Midwest Cardiovascular Research Foundation Welcomes DANITA HARRISON, ARNP Ms. Harrison discloses speaking relationships with Lilly, Novo Nordisk and Pfizer. Changing Diabetes: The time is now! Danita Harrison
More informationMetabolic Syndrome: Why Should We Look For It?
021-CardioCase 29/05/06 15:04 Page 21 Metabolic Syndrome: Why Should We Look For It? Dafna Rippel, MD, MHA and Andrew Ignaszewski, MD, FRCPC CardioCase presentation Andy s fatigue Andy, 47, comes to you
More informationlipid fraction of plasma concerned with the
By FRED B. MYOCARDIAL METABOLISM OF FATTY ACIDS * BALLARD, WILLIAM H. DANFORTH, SIEGFRIED NAEGLE AND RICHARD J. BING (From the Departments of Medicine, Washington University, St. Louis, Mo., and Wayne
More informationHormonal regulation of. Physiology Department Medical School, University of Sumatera Utara
Hormonal regulation of nutrient metabolism Physiology Department Medical School, University of Sumatera Utara Homeostasis & Controls Successful compensation Homeostasis reestablished Failure to compensate
More informationGlycogen Storage Disease
Glycogen Storage Disease 1 Introduction The food we eat is usually used for growth, tissue repair and energy. The body stores what it does not use. Excess sugar, or glucose, is stored as glycogen in the
More informationBlood Sugar, and Insulin during Carbohydrate-
Diurnal Patterns of Triglycerides, Free Fatty Acids, Blood Sugar, and Insulin during Carbohydrate- Induction in Man and Their Modification by Nocturnal Suppression of Lipolysis G. SCMEiEF and E. DOROW
More informationA Study to Show Postprandial Hypertriglyceridemia as a Risk Factor for Macrovascular Complications in Type 2 Diabetis Mellitus
Original Article Print ISSN: 2321-6379 Online ISSN: 2321-595X DOI: 10.17354/ijss/2018/21 A Study to Show Postprandial Hypertriglyceridemia as a Risk Factor for Macrovascular Complications in Bingi Srinivas
More informationSUMMARY. Introduction. Study design. Summary
SUMMARY Introduction The global prevalence of type 2 diabetes is increasing rapidly and nowadays affects almost 250 million people. Cardiovascular disease is the most prevalent complication of type 2 diabetes,
More informationTHE PLASMA LIPIDS IN CORONARY ARTERY DISEASE
THE PLASMA LIPIDS IN CORONARY ARTERY DISEASE BY M. F. OLIVER* AND G. S. BOYDt From the Dept. of Cardiology, Royal Infirmary, Edinburgh, and the Dept. of Biochemistry, Received June 8, 1953 University of
More informationA Closer Look at The Components Of a Balanced Diet
A Closer Look at The Components Of a Balanced Diet The essential nutrients are carbohydrates, fats, proteins, vitamins, minerals, dietary fibre and water. These nutrients will ensure that the systems and
More informationMetabolic Syndrome. Bill Roberts, M.D., Ph.D. Professor of Pathology University of Utah
Metabolic Syndrome Bill Roberts, M.D., Ph.D. Professor of Pathology University of Utah Objectives Be able to outline the pathophysiology of the metabolic syndrome Be able to list diagnostic criteria for
More informationNutrition, Food, and Fitness. Chapter 6 Fats: A Concentrated Energy Source
Nutrition, Food, and Fitness Chapter 6 Fats: A Concentrated Energy Source Tools: Printer (color optional) 4 sheets of 8.5 x 11 paper Scissors Directions: 1. Print 2. Fold paper in half vertically 3. Cut
More informationDYSLIPIDEMIA RECOMMENDATIONS
DYSLIPIDEMIA RECOMMENDATIONS Α. DIAGNOSIS Recommendation 1 INITIAL LIPID PROFILING (Level of evidence II) It is recommended to GPs and other PHC Physicians to assess the lipid profile {total cholesterol
More informationTotal risk management of Cardiovascular diseases Nobuhiro Yamada
Nobuhiro Yamada The worldwide burden of cardiovascular diseases (WHO) To prevent cardiovascular diseases Beyond LDL Multiple risk factors With common molecular basis The Current Burden of CVD CVD is responsible
More informationThe World Health Organization (WHO) has described diabetes mellitus as Metabolic
1.1. Background The World Health Organization (WHO) has described diabetes mellitus as Metabolic disorder of multiple etiology characterized by chronic hyperglycemia with disturbances of carbohydrate,
More information